Skip to main content
Part of Sickle Cell Disease on Somebody To Talk To
Loading page…
Preclinical Data on Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness in the Treatment of Sickle Cell Disease Presented at the American Society of Hematology Annual Meeting (2017 archive) | oneSCDvoice